In Vitro Evaluation of Curcumin-Encapsulated Chitosan Nanoparticles against Feline Infectious Peritonitis Virus and Pharmacokinetics Study in Cats

Figure 6

Concentration profile of curcumin in plasma versus time after (a) s.i.d. and (b) b.i.d. oral administration of curcumin or Cur-CS nanoparticles. Cur-CS: curcumin-encapsulated chitosan.

(a)

(b)